NUSSLOCH, Germany and VISTA, Calif., — Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquire Aperio, a leading provider of ePathology solutions. Aperio will be integrated into Leica Biosystems, a leader in anatomical pathology solutions. Together, the two businesses will leverage each other’s strengths to grow and expand digital pathology […]
Konstanz, Germany – As of today, PrenaTest® is available in more than 70 qualified prenatal diagnostic practices and clinics in Germany, Austria, Liechtenstein and Switzerland. PrenaTest® is a highly accurate non-invasive genetic blood test which is intended for use among women with pregnancies at high risk for fetal aneuploidy, specifically to detect fetal trisomy 21. […]
SAN FRANCISCO – Sequenta, Inc. and the Eastern Cooperative Oncology Group (now part of the ECOG-ACRIN Cancer Research Group) today announced an agreement to use Sequenta’s LymphoSIGHTTM next-generation sequencing method for the measurement of minimal residual disease (MRD) in a prospective clinical trial. E1411, whose primary goal is to study the effect of bortezomib and […]
ANN ARBOR, Mich., — Rubicon Genomics, Inc., today reported that its NovaPLEX™ family of sample preparation technologies is increasing the feasibility and utility of molecular diagnostic testing and helping to address the shortage of patient samples that is hampering new drug discovery and the development of personalized medicine. Rubicon is a leader in the development […]
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that the new BD MAX™ MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88). Performed on the fully-automated BD MAX™ System, the assay is designed to rapidly and […]
Increase Diagnostic Confidence and Laboratory Productivity With New Novocastra HD Antibodies for IHC
Leica Microsystems announces the introduction of the Novocastra(TM) HD antibody range, 80 clinically important immunohistochemistry antibody clones, spanning 10 anatomical pathologies. Novocastra HD was developed to meet the needs of pathologists and histologists, in terms of menu, diagnostic confidence and workflow. This new ‘Highly Definitive’ range was created following extensive global market research on customer […]
Today, Roche announced the launch of its new CE certified IVD version of the MagNA Pure 96 System for automated sample preparation. By providing a maximum of lot-to-lot consistency and highest quality, the new MagNA Pure 96 System is designed to even better fulfill the needs of diagnostic customers. In 2011, the IVD version of […]
AUSTIN, Texas, — Luminex Corporation (NASDAQ: LMNX) announced today it has been awarded a contract worth up to $11.6 million over three and a half years. The contract will fund development of a prototype instrument that is highly portable, field-deployable diagnostic tool capable of rapid detection of biothreat agents and patient response biomarkers indicative of […]
Melbourne, Australia: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE)announced today that it has received European CE Mark approval for BREVAGen™, the Company’s breast cancer risk test. The CE Mark designation will allow BREVAGen™ to be sold in the EU and other countries that recognise the CE Mark. The initial commercial focus will be in the […]
Epistem (AIM: EHP), the biotechnology and personalised medicine company, has announced that it has reached agreement with Becton Dickinson (BD) for the supply and distribution of its Mycobacterium tuberculosis (TB) test on a global basis (excluding India and the Indian Sub Continent) using its Genedrive™ platform. The TB supply and distribution agreement includes an upfront […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
